Published in J Clin Pathol on December 01, 2002
Expanded clinical and experimental use of SOX11 - using a monoclonal antibody. BMC Cancer (2012) 0.84
The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia (1994) 2.11
Mantle-cell lymphoma. Lancet Oncol (2001) 1.70
Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b). Am J Clin Pathol (1997) 1.54
Cytometry of cyclin proteins. Cytometry (1996) 1.40
Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma. Blood (1995) 1.34
Overexpression of cyclin D2 in chronic B-cell malignancies. Blood (1995) 1.26
Molecular diagnostic approach to non-Hodgkin's lymphoma. J Mol Diagn (2000) 1.19
p53 abnormalities in splenic lymphoma with villous lymphocytes. Blood (2001) 1.08
Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma. Oncogene (1995) 1.07
BCL-1/cyclin D1 oncoprotein oscillates and subverts the G1 phase control in B-cell neoplasms carrying the t(11;14) translocation. Oncogene (1994) 1.05
bcl-1 rearrangement and cyclin D1 protein expression in mantle cell lymphoma. J Pathol (1996) 0.92
The diagnosis of low-grade peripheral B-cell neoplasms in bone marrow trephines. Br J Haematol (2000) 0.90
Unusual case of leukemic mantle cell lymphoma with amplified CCND1/IGH fusion gene. Genes Chromosomes Cancer (2002) 0.90
Immunohistochemical analysis of cyclin D1 protein in hematopoietic neoplasms with special reference to mantle cell lymphoma. Jpn J Cancer Res (1994) 0.86
Cyclin D1 by flow cytometry as a useful tool in the diagnosis of B-cell malignancies. Leuk Res (2001) 0.86
Cyclin D1 overexpression allows identification of an aggressive subset of leukemic lymphoproliferative disorder. Leukemia (1999) 0.80
Variations in the low levels of cyclin D1/BCL1 have prognostic value in chronic lymphocytic leukemia. Leuk Res (2000) 0.80
Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol (1976) 13.98
Proposals for the classification of the myelodysplastic syndromes. Br J Haematol (1982) 10.90
Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med (1985) 6.82
Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial. Lancet (2007) 6.29
Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia (1995) 4.04
Adult T-cell lymphoma-leukaemia in Blacks from the West Indies. Lancet (1982) 3.67
Use of methoxamine in the resuscitation of epinephrine-resistant electromechanical dissociation. Anaesthesia (2001) 2.84
The human type-C retrovirus, HTLV, in Blacks from the Caribbean region, and relationship to adult T-cell leukemia/lymphoma. Int J Cancer (1982) 2.71
Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur J Biochem (1997) 2.63
A simplified method of detection of clonal rearrangements of the T-cell receptor-gamma chain gene. Diagn Mol Pathol (1992) 2.33
Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO) Br J Haematol (1991) 2.23
Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group. Ann Intern Med (1985) 2.22
Levels of expression of CD19 and CD20 in chronic B cell leukaemias. J Clin Pathol (1998) 2.21
The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group. Br J Haematol (1994) 2.20
Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group. J Clin Pathol (1989) 2.13
The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia (1994) 2.11
Hepatosplenic gamma delta T-cell lymphoma. A distinctive aggressive lymphoma type. Am J Surg Pathol (1995) 2.09
EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT. Gut (2011) 1.96
Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice. Blood (1998) 1.95
Fluid shear-induced mechanical signaling in MC3T3-E1 osteoblasts requires cytoskeleton-integrin interactions. Am J Physiol (1998) 1.89
Mechanisms for pro matrix metalloproteinase activation. APMIS (1999) 1.88
Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood (1991) 1.79
HTLV-1 infection in tropical spastic paraparesis: lymphocyte culture and serologic response. AIDS Res Hum Retroviruses (1988) 1.74
A specific IgG in Graves' ophthalmopathy and its relation to retro-orbital and thyroid autoimmunity. Br Med J (Clin Res Ed) (1984) 1.72
Mouse red-cell rosettes in B-lymphoproliferative disorders. Br J Haematol (1976) 1.72
Prolymphocytic leukaemia. Br J Haematol (1974) 1.66
Effect of HER2 on prognosis and benefit from peri-operative chemotherapy in early oesophago-gastric adenocarcinoma in the MAGIC trial. Ann Oncol (2012) 1.65
The morphological classification of acute lymphoblastic leukaemia: concordance among observers and clinical correlations. Br J Haematol (1981) 1.64
The association of eosinophilia with lymphoblastic leukaemia or lymphoma: a study of seven patients. Br J Haematol (1980) 1.63
Leukaemic phase of mantle zone (intermediate) lymphoma: its characterisation in 11 cases. J Clin Pathol (1989) 1.62
A novel monoclonal antibody BI-3C5 recognises myeloblasts and non-B non-T lymphoblasts in acute leukaemias and CGL blast crises, and reacts with immature cells in normal bone marrow. Leuk Res (1985) 1.61
A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. Br J Haematol (1997) 1.59
Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia. J Clin Oncol (1997) 1.57
Expression and functional analysis of G1 to S regulatory components reveals an important role for CDK2 in cell cycle regulation in human embryonic stem cells. Oncogene (2008) 1.55
High expression of CD23 in the proliferation centers of chronic lymphocytic leukemia in lymph nodes and spleen. Hum Pathol (1999) 1.55
Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b). Am J Clin Pathol (1997) 1.54
The rapid detection of clonal T-cell proliferations in patients with lymphoid disorders. Am J Pathol (1991) 1.53
B-ly-7, a monoclonal antibody reactive with hairy cell leukemia, also defines an activation antigen on normal CD8+ T cells. Blood (1990) 1.53
The morphological spectrum of T-prolymphocytic leukaemia. Br J Haematol (1986) 1.52
A multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resection. Ann Oncol (2011) 1.51
Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria. Leukemia (2007) 1.51
ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma. Ann Oncol (2013) 1.51
Screening for refractive errors in 6-9 month old infants by photorefraction. Br J Ophthalmol (1984) 1.50
Effect of M & B 17803A, a new -adrenoceptor blocking agent, on the cardiovascular responses to tilting and to isoprenaline in man. Br J Pharmacol (1971) 1.48
The role of plasminogen activators in the regulation of connective tissue metalloproteinases. Ann N Y Acad Sci (1992) 1.48
1,25-dihydroxyvitamin D3 inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cells. Leuk Res (1983) 1.48
Co-trimoxazole for prevention of infection in acute leukaemia. Lancet (1978) 1.47
Mycosis fungoides and Sezary syndrome are not associated with HTLV-I infection: an international study. Br J Haematol (1997) 1.47
Adult T-cell leukaemia/lymphoma in Brazil and its relation to HTLV-I. Lancet (1990) 1.47
The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. I. Clinical and laboratory features of 300 patients and characterization of an intermediate group. Br J Haematol (1986) 1.47
Molecular cloning of translocation t(1;14)(q21;q32) defines a novel gene (BCL9) at chromosome 1q21. Blood (1998) 1.46
T-lymphocyte colonies in normal blood, bone marrow and lymphoproliferative disorders. Clin Exp Immunol (1979) 1.46
Revised guideline on immunophenotyping in acute leukaemias and chronic lymphoproliferative disorders. Clin Lab Haematol (2002) 1.46
Outcome of biphenotypic acute leukemia. Haematologica (1999) 1.46
Hairy cell leukemia: a clinical review based on 71 cases. Ann Intern Med (1978) 1.46
Chronic myelomonocytic leukaemia. Br J Haematol (1975) 1.45
Evaluation of the efficacy of the VEEP regimen in adult Hodgkin's disease with assessment of gonadal and cardiac toxicity. J Clin Oncol (1995) 1.43
Acute myeloid leukaemia relapsing following interleukin-2 treatment expresses the alpha chain of the interleukin-2 receptor. Br J Haematol (1991) 1.42
The distribution of CD45R, CD29 and CD45RO (UCHL1) antigens in mature CD4 positive T-cell leukaemias. Br J Haematol (1990) 1.41
Mucinous histology predicts for reduced fluorouracil responsiveness and survival in advanced colorectal cancer. Ann Oncol (2005) 1.41
Central nervous system involvement demonstrated by immunological study in prolymphocytic variant of chronic lymphocytic leukemia. Acta Haematol (1989) 1.41
Rapid molecular cloning of rearrangements of the IGHJ locus using long-distance inverse polymerase chain reaction. Blood (1997) 1.41
Splenic B cell lymphoma with circulating villous lymphocytes: differential diagnosis of B cell leukaemias with large spleens. J Clin Pathol (1987) 1.40
Regulation of matrix metalloproteinase activity. Ann N Y Acad Sci (1994) 1.39
Septicaemia caused by viridans streptococci in neutropenic patients with leukaemia. Lancet (1984) 1.38
Definition of acute biphenotypic leukemia. Haematologica (1997) 1.37
The effect of cytomegalovirus on hemopoiesis: in vitro evidence for selective infection of marrow stromal cells. Exp Hematol (1989) 1.35
Multiparameter studies in lymphoid leukemias. Am J Clin Pathol (1979) 1.34
Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia. Nat Genet (1997) 1.32
Phenotypic heterogeneity and cellular origins of T cell malignancies. Leuk Res (1981) 1.32
Hairy-cell leukaemia and prolymphocytic leukaemia. Clin Haematol (1977) 1.31
Oral ketoconazole and amphotericin B for the prevention of yeast colonization in patients with acute leukaemia. J Hosp Infect (1984) 1.31
The role of pentostatin in the treatment of T-cell malignancies: analysis of response rate in 145 patients according to disease subtype. J Clin Oncol (1994) 1.30
Terminal deoxynucleotidyl-transferase levels and membrane phenotypes in diagnosis of acute leukaemia. Lancet (1977) 1.30
The variant form of hairy-cell leukaemia. Best Pract Res Clin Haematol (2003) 1.29
High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H. Blood (2001) 1.27
Transformation to "high grade" neuroendocrine carcinoma as an acquired drug resistance mechanism in EGFR-mutant lung adenocarcinoma. Lung Cancer (2013) 1.27
The B-lymphocyte nature of the hairy cell of leukaemic reticuloendotheliosis. Br J Haematol (1974) 1.27
Clinical significance of T-cells in chronic lymphocytic leukaemia. Lancet (1974) 1.26
Association of the human type C retrovirus with a subset of adult T-cell cancers. Cancer Res (1983) 1.25
Levels of expression of CD52 in normal and leukemic B and T cells: correlation with in vivo therapeutic responses to Campath-1H. Leuk Res (1998) 1.25